Announcements Trials
Browse Landscape

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 17Observational 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Breast Neoplasms 2234Neoplasms 2039Lung Neoplasms 1097Colorectal Neoplasms 1036Prostatic Neoplasms 894Carcinoma, Non-Small-Cell Lung 752Carcinoma, Hepatocellular 674Stomach Neoplasms 607Pancreatic Neoplasms 602Head and Neck Neoplasms 434Ovarian Neoplasms 430Colonic Neoplasms 423Rectal Neoplasms 406Uterine Cervical Neoplasms 403Esophageal Neoplasms 347Brain Neoplasms 329Neoplasm Metastasis 324Melanoma 306Multiple Myeloma 304Precursor Cell Lymphoblastic Leukemia-Lymphoma 293Urinary Bladder Neoplasms 290Leukemia, Myeloid, Acute 278Lymphoma 268Liver Neoplasms 253Endometrial Neoplasms 253Hematologic Neoplasms 252Disease 244Recurrence 225Glioma 218Carcinoma, Renal Cell 207

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Observational × Non-small Cell Lung Cancer Metastatic × Clear all
NCT01523340 2021-08-03

MENTOR

Chonnam National University Hospital

Completed
196 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT02228421 2020-03-11

Study to Evaluate Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients

PeriPharm

Terminated
29 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT02041468 2017-08-30

Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients

Jewish General Hospital

Unknown
29 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡